pentobarbital will reduce the extent or impact of aripiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.pentobarbital will lessen the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is usually a delicate CYP3A4 substrate. Coadministration with
pentobarbital will reduce the level or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Use of other treatment options is strongly advised when linagliptin is always to be administered with a CYP3A4 inducerpentobarbital will minimize the extent or influence of armodafinil by affecting hep
pentobarbital will lessen the level or impact of buprenorphine buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.pentobarbital will reduce the extent or outcome of bexarotene by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.pentobarbital will lower the extent or outcome o